GPS: Adaptation Trial of an HIV Prevention Counselling Program for HIV-positive and HIV-negative Gay and Bisexual Men
NCT ID: NCT03186183
Last Updated: 2020-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2017-09-01
2019-07-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention Research to Reduce HIV Sexual Transmission Among HIV Positive Men Who Have Sex With Men
NCT01816828
A Small-group Intervention to Reduce HIV Sexual Transmission Risk Behavior Among HIV-positive Men Who Have Sex With Men
NCT02546271
The SPOT Project : Motivational Interviewing in Conjunction With Rapid HIV Testing
NCT01931345
Filling Gaps in the HIV Pre-exposure Prophylaxis Cascade Through Counseling
NCT06710171
Providing Online Counseling for Home-Based HIV Testing With Transgender Youth
NCT03185975
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GPS program
The individual GPS motivational interviewing counseling program has 4-6 sessions.
Week 1: information on sexually transmitted infections and HIV disclosure laws is reviewed. Participants are introduced to the sex diary, stress exercise, and stages of change model.
Week 2: a decisional balance exercise about the participant's current sexual behavior is completed and a behavioral goal is chosen.
Week 3: participants explore their greatest fears and hopes about the goal, and the importance of and their confidence in achieving it.
Week 4: the facilitator and participant identify triggers, automatic thoughts, counters, strategies, supports, and rewards pertaining to the pursuit of the goal and role play the new goal.
1-2 supplemental sessions may be added as needed.
GPS program
GPS is a sexual health promotion and HIV prevention program. It has 4 components: provision of information on HIV and sexually transmitted infections, motivational interviewing counselling, sexual health behavioural skills building, and linkage to care in the local community (e.g., referrals to medical, social service, social, mental health, and substance use programs). Among HIV-positive men who have sex with men (MSM) GPS is associated with positive health outcomes including decreased likelihood of condomless anal sex (CAS), particularly CAS with serodiscordant partners. GPS is also associated with decreased fear of being rejected for insisting on condom use and increased condom use self-efficacy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GPS program
GPS is a sexual health promotion and HIV prevention program. It has 4 components: provision of information on HIV and sexually transmitted infections, motivational interviewing counselling, sexual health behavioural skills building, and linkage to care in the local community (e.g., referrals to medical, social service, social, mental health, and substance use programs). Among HIV-positive men who have sex with men (MSM) GPS is associated with positive health outcomes including decreased likelihood of condomless anal sex (CAS), particularly CAS with serodiscordant partners. GPS is also associated with decreased fear of being rejected for insisting on condom use and increased condom use self-efficacy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* self-identify as a man
* self-identify as gay, bisexual, queer, same-gender-loving, or a man who has sex with men
* report having engaged in condomless anal sex in the last 3 months
* able to speak, read, and aurally comprehend English
* depending on the study site, report HIV-negative or HIV-positive status
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Health Initiative for Men
UNKNOWN
Regional HIV/AIDS Connection
UNKNOWN
AIDS Committee of Toronto
OTHER
Gay ZONE
UNKNOWN
The Ottawa Hospital
OTHER
University of Victoria
OTHER
University of Windsor
OTHER
Ottawa Hospital Research Institute
OTHER
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
MAX Ottawa
UNKNOWN
Toronto Metropolitan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Trevor Hart
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Trevor Hart, PhD
Role: PRINCIPAL_INVESTIGATOR
Toronto Metropolitan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Initiative for Men
Vancouver, British Columbia, Canada
Regional HIV/AIDS Connection
London, Ontario, Canada
Immunodeficiency Clinic - The Ottawa Hospital
Ottawa, Ontario, Canada
Gay ZONE (Centretown Community Health Centre)
Ottawa, Ontario, Canada
MAX Ottawa
Ottawa, Ontario, Canada
AIDS Committee of Toronto
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REB 2016-282
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.